News headlines about Valeritas Holdings (NASDAQ:VLRX) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Valeritas Holdings earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.0899292439925 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the media headlines that may have effected Accern’s rankings:

Several equities analysts have recently issued reports on the stock. B. Riley reissued a “buy” rating and issued a $10.00 price target on shares of Valeritas Holdings in a report on Wednesday, May 17th. ValuEngine raised shares of Valeritas Holdings from a “strong sell” rating to a “sell” rating in a report on Friday, June 2nd. Finally, Wedbush assumed coverage on shares of Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 price target for the company.

Shares of Valeritas Holdings (NASDAQ:VLRX) traded down 7.42% during trading on Friday, hitting $3.12. 26,509 shares of the stock traded hands. The firm has a 50-day moving average of $5.25 and a 200-day moving average of $10.36. Valeritas Holdings has a 1-year low of $2.90 and a 1-year high of $50.00. The firm’s market capitalization is $21.35 million.

Valeritas Holdings (NASDAQ:VLRX) last announced its quarterly earnings data on Friday, August 11th. The company reported ($1.83) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.87) by $0.04. The firm had revenue of $4.79 million for the quarter, compared to analysts’ expectations of $5.11 million. On average, equities analysts forecast that Valeritas Holdings will post ($8.60) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Valeritas Holdings (VLRX) Earning Somewhat Positive News Coverage, Study Shows” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at

About Valeritas Holdings

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Insider Buying and Selling by Quarter for Valeritas Holdings (NASDAQ:VLRX)

Receive News & Stock Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related stocks with our FREE daily email newsletter.